Department of Cardiology University Hospital Basel Basel Switzerland.
Cardiovascular Research Institute Basel, University Hospital Basel Basel Switzerland.
J Am Heart Assoc. 2022 Aug 2;11(15):e026239. doi: 10.1161/JAHA.122.026239. Epub 2022 Jul 25.
Background Despite being the most frequent complication following transcatheter aortic valve replacement (TAVR), optimal management of left bundle-branch block (LBBB) remains unknown. Electrophysiology study has been proposed for risk stratification. However, the optimal timing of electrophysiology study remains unknown. We aimed to investigate the temporal dynamics of atrioventricular conduction in patients with new-onset LBBB after TAVR by performing serial electrophysiology study and to deduce a treatment strategy. Methods and Results We assessed consecutive patients undergoing TAVR via His-ventricular interval measurement prevalve and postvalve deployment and the day after TAVR. Infranodal conduction delay was defined as a His-ventricular interval >55 milliseconds. Among 107 patients undergoing TAVR, 53 patients (50%) experienced new-onset LBBB postvalve deployment and infranodal conduction delay was noted in 24 of 53 patients intraprocedurally (45%). LBBB resolved the day after TAVR in 35 patients (66%). In patients with new-onset LBBB postvalve deployment and no infrahisian conduction delay intraprocedurally, the His-ventricular interval did not prolong in any patient to >55 milliseconds the following day. Overall, 4 patients (7.5%) with new-onset LBBB after TAVR were found to have persistent infrahisian conduction delay 24 hours after TAVR. During 30-day follow-up, 1 patient (1.1%) with new LBBB and a normal His-ventricular interval after TAVR developed new high-grade atrioventricular block. Conclusions Among patients with new-onset LBBB postvalve deployment, infrahisian conduction delay can safely be excluded intraprocedurally, suggesting that early intracardiac intraprocedural conduction studies may be of value in these patients.
背景 尽管左束支传导阻滞(LBBB)是经导管主动脉瓣置换术(TAVR)后最常见的并发症,但最佳的 LBBB 管理方法仍不清楚。已有研究提出电生理检查可用于风险分层。然而,电生理检查的最佳时机仍不清楚。我们旨在通过连续进行电生理研究来探讨 TAVR 后新发 LBBB 患者房室传导的时变特征,并推演出一种治疗策略。
方法和结果 我们评估了连续接受 TAVR 的患者,在瓣上和瓣下测量希氏束-心室间期,并在 TAVR 后第 1 天进行测量。希氏束-心室间期>55 毫秒定义为下传传导延迟。在 107 例接受 TAVR 的患者中,53 例(50%)患者瓣下后出现新发 LBBB,其中 24 例(45%)患者术中存在下传传导延迟。35 例患者(66%)在 TAVR 后第 1 天 LBBB 得到缓解。在瓣下后新发 LBBB 且术中无希氏束下传导延迟的患者中,第 2 天没有患者的希氏束-心室间期延长至>55 毫秒。总体而言,4 例(7.5%)患者瓣下后新发 LBBB,24 小时后 TAVR 仍存在希氏束下传导延迟。在 30 天随访中,1 例(1.1%)新发 LBBB 且 TAVR 后希氏束-心室间期正常的患者新发高度房室传导阻滞。
结论 在瓣下后新发 LBBB 的患者中,术中可安全排除希氏束下传导延迟,这提示早期心内术中电生理检查可能对这些患者有价值。